SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001562762-20-000269
Filing Date
2020-08-04
Accepted
2020-08-04 15:05:59
Documents
54
Period of Report
2020-06-27

Document Format Files

Seq Description Document Type Size
1 10-Q usna-20200627x10q.htm   iXBRL 10-Q 2671000
2 EX-31.1 usna-20200627xex31_1.htm EX-31.1 14924
3 EX-31.2 usna-20200627xex31_2.htm EX-31.2 15198
4 EX-32.1 usna-20200627xex32_1.htm EX-32.1 6345
5 EX-32.2 usna-20200627xex32_2.htm EX-32.2 6261
  Complete submission text file 0001562762-20-000269.txt   6962486

Data Files

Seq Description Document Type Size
6 EX-101.SCH usna-20200627.xsd EX-101.SCH 25705
7 EX-101.CAL usna-20200627_cal.xml EX-101.CAL 42803
8 EX-101.DEF usna-20200627_def.xml EX-101.DEF 46417
9 EX-101.LAB usna-20200627_lab.xml EX-101.LAB 210256
10 EX-101.PRE usna-20200627_pre.xml EX-101.PRE 174727
11 EXTRACTED XBRL INSTANCE DOCUMENT usna-20200627x10q_htm.xml XML 1400610
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

IRS No.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: 10-Q | Act: 34 | File No.: 001-35024 | Film No.: 201072915
SIC: 2833 Medicinal Chemicals & Botanical Products